Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • HER2 amplification in Uterine...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
HER2 amplification in Uterine carcinosarcoma after tamoxifen therapy: a case report

HER2 amplification in Uterine carcinosarcoma after tamoxifen therapy: a case report

Bibliographic Details
Main Authors: Fuqiang Zheng, Xiaocai Tian
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Obstetrics and Gynaecology
Subjects:
uterine carcinosarcoma
tamoxifen
her-2
next generation sequencing
gynaecological oncology
Online Access:http://dx.doi.org/10.1080/01443615.2022.2125301
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://dx.doi.org/10.1080/01443615.2022.2125301

Similar Items

  • Uterine Carcinosarcoma Associated with Tamoxifen Use in a Menopausal ‎Patient: A Case Report ‎
    by: T Ashrafganjoei, et al.
    Published: (2015-12-01)
  • cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma
    by: Huseyin Salih SEMIZ, et al.
    Published: (2023-01-01)
  • Clinicopathological and molecular analyses of uterine carcinosarcomas using next-generation sequencing: A single-center experience
    by: Ezgi Genç Erdoğan, et al.
    Published: (2023-07-01)
  • Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
    by: Jonathan T. Hunt, et al.
    Published: (2021-08-01)
  • The efficacy and safety of lenvatinib plus pembrolizumab therapy in patients with uterine carcinosarcoma
    by: Risako Ozawa, et al.
    Published: (2024-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs